Log in to save to my catalogue

Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction

Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f1801bc1fcbb47b0914afdf6951006ad

Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction

About this item

Full title

Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction

Publisher

Germany: John Wiley & Sons, Inc

Journal title

Journal of cachexia, sarcopenia and muscle, 2023-02, Vol.14 (1), p.391-405

Language

English

Formats

Publication information

Publisher

Germany: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Age‐associated sarcopenia is characterized of progressed loss of skeletal muscle power, mass, and function, which affects human physical activity and life quality. Besides, accompanied with sarcopenia, aged population also faces a series of metabolic dysfunctions. Irisin, the cleaved form of fibronectin type III domain‐containing prot...

Alternative Titles

Full title

Irisin ameliorates age‐associated sarcopenia and metabolic dysfunction

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f1801bc1fcbb47b0914afdf6951006ad

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f1801bc1fcbb47b0914afdf6951006ad

Other Identifiers

ISSN

2190-5991

E-ISSN

2190-6009

DOI

10.1002/jcsm.13141

How to access this item